No Data
No Data
Jones Trading Initiates Coverage On Editas Medicine With Buy Rating, Announces Price Target of $13
JonesTrading Initiates Editas Medicine(EDIT.US) With Buy Rating, Announces Target Price $13
JonesTrading analyst Soumit Roy initiates coverage on $Editas Medicine(EDIT.US)$ with a buy rating, and sets the target price at $13.According to TipRanks data, the analyst has a success rate of 23.5%
Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
Editas Medicine to Participate in Upcoming Investor Conferences
Editas Medicine, Inc. (NASDAQ:EDIT) Looks Inexpensive After Falling 32% But Perhaps Not Attractive Enough
We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate